Bi and colleagues demonstrated that MSI-1 expression was strong in breast cancer subpopulations with high metastatic potential and increased cell invasion and circulating tumor cells, potentially by downregulating TIMP3 [61]. The gene discussed is MSI1; the disease is breast carcinoma.